These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29878051)

  • 1. Revealing Measles Outbreak Risk With a Nested Immunoglobulin G Serosurvey in Madagascar.
    Winter AK; Wesolowski AP; Mensah KJ; Ramamonjiharisoa MB; Randriamanantena AH; Razafindratsimandresy R; Cauchemez S; Lessler J; Ferrari MJ; Metcalf CJE; Héraud JM
    Am J Epidemiol; 2018 Oct; 187(10):2219-2226. PubMed ID: 29878051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K; Mutembo S; Carcelen A; Matakala HK; Munachoonga P; Winter A; Wanyiri JW; Searle K; Mwansa FD; Mwiche A; Phiri C; Book C; Thuma PE; Moss WJ
    Vaccine; 2019 Apr; 37(17):2387-2393. PubMed ID: 30905529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K
    PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles seroprevalence, outbreaks, and vaccine coverage in Rwanda.
    Seruyange E; Gahutu JB; Mambo Muvunyi C; Uwimana ZG; Gatera M; Twagirumugabe T; Katare S; Karenzi B; Bergström T
    Infect Dis (Lond); 2016; 48(11-12):800-7. PubMed ID: 27386895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.
    Ristić M; Milošević V; Medić S; Djekić Malbaša J; Rajčević S; Boban J; Petrović V
    PLoS One; 2019; 14(5):e0216219. PubMed ID: 31071124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile.
    Bechini A; Boccalini S; Tiscione E; Pesavento G; Mannelli F; Peruzzi M; Rapi S; Mercurio S; Bonanni P
    Eur J Public Health; 2012 Feb; 22(1):133-9. PubMed ID: 20880991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.
    Mossong J; Putz L; Schneider F
    Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012.
    Fitter DL; Anselme R; Paluku G; Rey G; Flannery B; Tohme RA; Marston BJ; Griswold M; Boncy J; Vertefeuille JF
    Vaccine; 2013 Dec; 32(1):69-73. PubMed ID: 24188751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L; Germann D; Bally F; Schopfer K
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
    Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
    Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts.
    Doshi S; Khetsuriani N; Zakhashvili K; Baidoshvili L; Imnadze P; Uzicanin A
    Int J Epidemiol; 2009 Feb; 38(1):182-91. PubMed ID: 19074954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles outbreak in 2018-2019, Madagascar: epidemiology and public health implications.
    Nimpa MM; Andrianirinarison JC; Sodjinou VD; Douba A; Masembe YV; Randriatsarafara F; Ramamonjisoa CB; Rafalimanantsoa AS; Razafindratsimandresy R; Ndiaye CF; Rakotonirina J
    Pan Afr Med J; 2020; 35():84. PubMed ID: 32537087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How much does it cost to measure immunity? A costing analysis of a measles and rubella serosurvey in southern Zambia.
    Carcelen AC; Hayford K; Moss WJ; Book C; Thuma PE; Mwansa FD; Patenaude B
    PLoS One; 2020; 15(10):e0240734. PubMed ID: 33057405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China.
    Chong KC; Zhang C; Zee BC; Luo T; Wang L; Tam GC; Jia KM; Sun R; Wang MH; Guan X
    Vaccine; 2017 Feb; 35(7):1024-1029. PubMed ID: 28111146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiology and evaluation of passive surveillance during 1988-1989 measles outbreak in Taiwan.
    Lee MS; King CC; Jean JY; Kao CL; Wang CC; Ho MS; Chen CJ; Lee GC
    Int J Epidemiol; 1992 Dec; 21(6):1165-74. PubMed ID: 1483823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Madagascar 2018-2019 measles outbreak response: main strategic areas.
    Sodjinou VD; Douba A; Nimpa MM; Masembe YV; Randria M; Ndiaye CF
    Pan Afr Med J; 2020; 37():20. PubMed ID: 33062122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating Blood Collection within Household Surveys: Lessons Learned from Nesting a Measles and Rubella Serological Survey within a Post-Campaign Coverage Evaluation Survey in Southern Province, Zambia.
    Mutembo S; Carcelen A; Mwansa FD; Searle K; Wanyiri JW; Book C; Thuma PE; Moss WJ; Hayford K
    Am J Trop Med Hyg; 2018 Dec; 99(6):1639-1642. PubMed ID: 30277204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.